Xeris Biopharma Holdings
(NASDAQ:XERS)
Xeris Biopharma Holdings, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Xeris Biopharma Holdings, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$1.87
0.05[2.75%]
At close: Aug 12
$1.84
-0.0300[-1.60%]
After Hours: 4:29PM EDT
Day High/Low1.82 - 1.94
52 Week High/Low1.25 - 3.1
Open / Close1.86 / 1.87
Float / Outstanding121.5M / 136M
Vol / Avg.917.8K / 1.6M
Mkt Cap254.2M
P/E-
50d Avg. Price1.67
Div / Yield-
Payout Ratio-
EPS-0.19
Total Float121.5M

Xeris Biopharma Holdings (NASDAQ:XERS), Quotes and News Summary

Xeris Biopharma Holdings (NASDAQ: XERS)

Day High/Low1.82 - 1.94
52 Week High/Low1.25 - 3.1
Open / Close1.86 / 1.87
Float / Outstanding121.5M / 136M
Vol / Avg.917.8K / 1.6M
Mkt Cap254.2M
P/E-
50d Avg. Price1.67
Div / Yield-
Payout Ratio-
EPS-0.19
Total Float121.5M
Sector: Health Care.Industry: Pharmaceuticals
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Xeris Biopharma Holdings Questions & Answers

Q
How do I buy Xeris Biopharma Holdings (XERS) stock?
A

You can purchase shares of Xeris Biopharma Holdings (NASDAQ: XERS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Xeris Biopharma Holdings's (XERS) competitors?
Q
What is the target price for Xeris Biopharma Holdings (XERS) stock?
A

The latest price target for Xeris Biopharma Holdings (NASDAQ: XERS) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting XERS to rise to within 12 months (a possible 113.90% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Xeris Biopharma Holdings (XERS)?
A

The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $1.87 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Xeris Biopharma Holdings (XERS) pay a dividend?
A

The next Xeris Biopharma Holdings (XERS) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Xeris Biopharma Holdings (NASDAQ:XERS) reporting earnings?
A

Xeris Biopharma Holdings’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Xeris Biopharma Holdings (XERS) going to split?
A

There is no upcoming split for Xeris Biopharma Holdings.

Q
What sector and industry does Xeris Biopharma Holdings (XERS) operate in?
A

Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.